SIMEPREVIR PLUS PEGINTERFERON/RIBAVIRIN COST-EFFECTIVENESS ANALYSIS FOR THE TREATMENT OF CHRONIC GENOTYPE 1 HEPATITIS C IN COLOMBIA

被引:1
|
作者
Ariza, J. G. [1 ]
Taborda, A. [2 ]
Naciben, V [3 ]
Heibeck, M. [4 ]
Westerhout, K. Y. [5 ]
机构
[1] Janssen, Bogota, Colombia
[2] Johnson & Johnson, Sao Paulo, SP, Brazil
[3] Janssen Pharmaceut, Sao Paulo, Brazil
[4] Pharmerit Int, Berlin, Germany
[5] Pharmerit Int, Rotterdam, Netherlands
关键词
D O I
10.1016/j.jval.2015.09.020
中图分类号
F [经济];
学科分类号
02 ;
摘要
PIN26
引用
收藏
页码:A872 / A872
页数:1
相关论文
empty
未找到相关数据